Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital
- PMID: 19199531
- DOI: 10.1086/595977
Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital
Abstract
Objective: To describe what is, to our knowledge, the first nosocomial outbreak of infection with pan-drug-resistant (including colistin-resistant) Acinetobacter baumannii, to determine the risk factors associated with these types of infections, and to determine their clinical impact.
Design: Nested case-control cohort study and a clinical-microbiological study.
Setting: A 1,521-bed tertiary care university hospital in Seville, Spain.
Patients: Case patients were inpatients who had a pan-drug-resistant A. baumannii isolate recovered from a clinical or surveillance sample obtained at least 48 hours after admission to an intensive care unit (ICU) during the time of the epidemic outbreak. Control patients were patients who were admitted to any of the "boxes" (ie, rooms that partition off a distinct area for a patient's bed and the equipment needed to care for the patient) of an ICU for at least 48 hours during the time of the epidemic outbreak.
Results: All the clinical isolates had similar antibiotic susceptibility patterns (ie, they were resistant to all the antibiotics tested, including colistin), and, on the basis of repetitive extragenic palindromic-polymerase chain reaction, it was determined that all of them were of the same clone. The previous use of quinolones and glycopeptides and an ICU stay were associated with the acquisition of infection or colonization with pan-drug-resistant A. baumannii. To control this outbreak, we implemented the following multicomponent intervention program: the performance of environmental decontamination of the ICUs involved, an environmental survey, a revision of cleaning protocols, active surveillance for colonization with pan-drug-resistant A. baumannii, educational programs for the staff, and the display of posters that illustrate contact isolation measures and antimicrobial use recommendations.
Conclusions: We were not able to identify the common source for these cases of infection, but the adopted measures have proven to be effective at controlling the outbreak.
Similar articles
-
Nosocomial outbreak of infection with multidrug-resistant Acinetobacter baumannii in a medical center in Taiwan.Infect Control Hosp Epidemiol. 2009 Jan;30(1):34-8. doi: 10.1086/592704. Infect Control Hosp Epidemiol. 2009. PMID: 19049437
-
Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit.Infect Control Hosp Epidemiol. 2008 May;29(5):410-7. doi: 10.1086/533545. Infect Control Hosp Epidemiol. 2008. PMID: 18419362
-
Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit.Infect Control Hosp Epidemiol. 2007 Apr;28(4):423-9. doi: 10.1086/513120. Epub 2007 Mar 16. Infect Control Hosp Epidemiol. 2007. PMID: 17385148
-
Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Future Microbiol. 2011 Apr;6(4):407-22. doi: 10.2217/fmb.11.23. Future Microbiol. 2011. PMID: 21526942 Review.
-
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.Int J Antimicrob Agents. 2012 Feb;39(2):105-14. doi: 10.1016/j.ijantimicag.2011.10.004. Epub 2011 Nov 22. Int J Antimicrob Agents. 2012. PMID: 22113193 Review.
Cited by
-
Loss of Lipooligosaccharide Synthesis in Acinetobacter baumannii Produces Changes in Outer Membrane Vesicle Protein Content.Int J Mol Sci. 2024 Aug 27;25(17):9272. doi: 10.3390/ijms25179272. Int J Mol Sci. 2024. PMID: 39273220 Free PMC article.
-
Genome sequence analysis of an extensively drug-resistant Acinetobacter baumannii indigo-pigmented strain depicts evidence of increase genome plasticity.Sci Rep. 2018 Nov 16;8(1):16961. doi: 10.1038/s41598-018-35377-5. Sci Rep. 2018. PMID: 30446709 Free PMC article.
-
A multimodal intervention program to control a long-term Acinetobacter baumannii endemic in a tertiary care hospital.Antimicrob Resist Infect Control. 2019 Dec 4;8:199. doi: 10.1186/s13756-019-0658-4. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31827780 Free PMC article.
-
Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.Virulence. 2018 Dec 31;9(1):930-942. doi: 10.1080/21505594.2018.1460187. Virulence. 2018. PMID: 29638177 Free PMC article.
-
The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.PLoS Pathog. 2018 May 10;14(5):e1007056. doi: 10.1371/journal.ppat.1007056. eCollection 2018 May. PLoS Pathog. 2018. PMID: 29746596 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources